566-567 / 2351
DAHANCA 6 & 7 - 1476 patients
60
80
100
regional control (%)
70%
60%
6 Fx
5 Fx
Loco-regional control – acc. RT
0
12
24
36
48
60
Time after treatment (months)
0
20
40
Loco-
P=0.0005
All
Failure
5 Fx
726 274
6 Fx
750 211
Overgaard
et al.
Lancet 2003